Abstract

Implantable drug delivery systems [IDDS] provide a viable substitute for conventional medication delivery techniques. The most popular medication delivery methods, oral and injectable, frequently cause blood drug concentrations to peak and then fall. This calls for ongoing administration in order to sustain therapeutic medication levels. Oral medication distribution also has to contend with issues such first-pass metabolism and drug degradation in the gastrointestinal system. Conversely, IDDS allow for prolonged medication release, which makes them particularly useful for treating chronic illnesses where patients may find it challenging to adhere to traditional treatment regimens. These systems can be used for localized therapy, focusing on certain regions to optimize drug concentration at the site of action and reduce systemic exposure, even though they are usually utilized for systemic drug delivery.